Non-invasive Prenatal Testing (NIPT): Better Meet an Expert!

Abstract

While NIPT is being implemented rapidly, the implementation of a corresponding specialized counselling process in many respects lags behind. As a consequence, legal requirements and other testing conditions sometimes are not fulfilled adequately. The reported case illustrates the importance of trained personnel in the counselling and NIPT process and shows so far neglected risks for the pregnant woman and her reproductive autonomy.

Zusammenfassung

Während der nicht invasive pränatale Bluttest (NIPT) unaufhaltsam Einzug in die Praxis hält, hinkt die Implementierung eines darauf abgestimmten Beratungsprozesses in vielen Bereichen noch hinterher, sodass gesetzliche Regelungen und andere Testvoraussetzungen nicht immer eingehalten werden. Der hier beschriebene Fall eines Spätabbruchs nach missglücktem NIPT-Einsatz zeigt die Notwendigkeit von aktuellem Fortbildungsstand und Expertise bei den Anbietenden sowie die Risiken für die reproduktive Autonomie, wenn diese Bedingungen nicht erfüllt sind.

Key words

NIPT - prenatal diagnosis - counselling - trisomy 13 - abortion

Schlüsselwörter

NIPT - Pränataldiagnostik - Beratung - Trisomie 13 - Spätabbruch

• References

• 1 American College of Obstetricians and Gynecologists (ACOG). Committee opinion no. 640: Cell-free DNA screening for fetal aneuploidy. Published electronically ahead of print on June 26, 2015. Online: http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Genetics/Cell-free-DNA-Screening-for-Fetal-Aneuploidy last access: 06.12.2015
• 2 Devers PL, Cronister A, Ormond KE et al. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Couns 2013; 22: 291-295
• 3 The Royal College of Obstetricians & Gynecologists (RCOG). Non-invasive prenatal testing for chromosomal abnormality using maternal plasma DNA. Scientific Impact Paper No. 15, March 2014. Online: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/sip15/ last access: 06.12.2015
• 4 Dondorp W, de Wert G, Bombard Y et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet 2015; 23: 1438-1450
• 5 Dar P, Curnow KJ, Gross SJ et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 2014; 211: 527
• 6 Warsof SL, Larion S, Abuhamad AZ. Overview of the impact of noninvasive prenatal testing on diagnostic procedures. Prenat Diagn 2015; 35: 972-979
• 7 NHS RAPID project. Online: http://www.rapid.nhs.uk/ last access: 06.12.2015
• 8 NIPT consortium. http://
• 9 Haymon L, Simi E, Moyer K et al. Clinical implementation of non-invasive prenatal testing among maternal fetal medicine specialists. Prenat Diagn 2014; 34: 416-423
• 10 Benn P, Chapman AR, Erickson K et al. Obstetricians and gynecologistsʼ practice and opinions of expanded carrier testing and noninvasive prenatal testing. Prenat Diagn 2014; 34: 145-152
• 11 Vanstone M, King C, de Vrijer B et al. Non-invasive prenatal testing: ethics and policy considerations. J Obstet Gynecol Can 2014; 36: 515-526
• 12 Schmitz D. Terminating pregnancy after prenatal diagnosis – with a little help of professional ethics?. J Med Ethics 2012; 38: 399-402
• 13 Bianchi DW, Parker RL, Wentworth J et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370: 799-808
• 14 Kagan KO, Hoopmann M, Hammer R et al. Screening for chromosomal abnormalities by first trimester combined screening and noninvasive prenatal testing. Ultraschall Med 2015; 36: 40-46
• 15 Quezada MS, Gil MM, Francisco C et al. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10–11 weeksʼ gestation and the combined test at 11–13 weeks. Ultrasound Obstet Gynecol 2015; 45: 36-41